Roth/MKM Downgrades NeuroSense Therapeutics Ltd. (NRSN) to Neutral

October 12, 2026 4:37 PM EDT Send to a Friend
Roth/MKM analyst Boobalan Pachaiyappan downgraded NeuroSense Therapeutics Ltd. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login